10月30日口譯文章：環球開創3D生物血管打印機在成都問世
本周日，中國的一家生物技巧公司宣告，它已研發出了天下上第一台3D血管生物打印機，這使得制作個別功效器官成為大概。
處於中國西南部四川省省城成都的四川Revotek公司稱，經由過程公司本身研發的幹細胞生物銜接技巧、3D生物打印機和雲盤算平台，3D血管生物打印機這一具備劃時期的意義的技巧沖破已完成。
四川藍光成長公司主席楊鏗說，“這一具備立異性的3D血管印刷機的創造，象征著咱們已控制了幹細胞為基本的3D生物打印技巧”。Revotek是四川藍光團體的子公司。
據引導該項目標專家James Kang說，當發明任何器官的時刻，向各器官輸送養分物資的血管是必弗成少的。
康的研發團隊已發明了一個新的生物鏈接模式- Biosynsphere，這一鏈接模式的重要目的是個別幹細胞生物打印，以便器官再生。
他說，“咱們已勝利地經由過程依附3D打印機，biosynsphere技巧和雲盤算基本上的數據模子實現了血管再生。”
公司很樂意接收更多的人材而且追求國際公司來運用這一造詣。
【參考譯文】
A Chinese biotechnological company announced on Sunday it has developed the world's first 3D blood vessel bio-printer, which makes it possible to produce personalized functional organs.
Sichuan Revotek Co., Ltd. based in Chengdu, capital of southwest China's Sichuan Province, said the significant breakthrough has been achieved through its self-developed stem cell bio-ink technology, 3D bio-printer and cloud computing platform.
"The creative breakthrough in the 3D blood vessel bio-printing means we have mastered the stem cell-based 3D bio-printing technology," said Yang Keng, chairman of Sichuan Languang Development Co., Ltd. Revotek is a subsidiary of Sichuan Languang.
Blood vessels that transport nutrients to organs are indispensable elements when creating any organs, according to James Kang, an expert who led the program.
Kang's team has created a novel type of bio-ink - "Biosynsphere", whose primary goal is the personalized stem cell bio-printing to pave the way for organ regeneration.
"We have successfully realized the blood vessel regeneration by relying on the 3D bio-printer, the biosynsphere technology and the data model based on cloud computing," he said.
The company said it is willing to absorb more talent and seek international cooperation for the application of the achievements.
市場價：HK$ 110
